Diagnosis and treatment of Fibromyalgia: a comprehensive review of current evidence and clinical practices

• Autores: Guilherme Quireza Silva, Jairo Belém Soares Ribeiro Júnior, Patricia Regina Alves Galdeano, Pedro Antonio Galdeano, Lenita Vieira Braga, Larissa Rodrigues Alves, Adriano Luis Fonseca, Luís Vicente Franco de Oliveira
• Localización: Cuadernos de Educación y Desarrollo, ISSN-e 1989-4155, Vol. 16, Nº. 10, 2024
• Idioma: portugués
• Enlaces
  • Texto completo
• Resumen

  • Fibromyalgia is a chronic condition that causes fatigue, sleep disturbances, cognitive impairment, and widespread pain in the muscles and bones. The latest evidence-based methods for diagnosing and treating fibromyalgia are examined in this article. The diagnostic criteria have improved, making the Symptom Severity Scale (SSS) and the Widespread Pain Index (WPI) crucial for patient assessment. This study searched PubMed, Scopus, and Web of Science from 1990 to 2023 and selected 44 publications for in-depth analysis. To ensure the accurate application of the criteria, the diagnosis and treatment of fibromyalgia were the focus of this investigation through the synthesis of qualitative data. Medications can relieve pain and improve quality of life when used early on. Anticonvulsants, tricyclic antidepressants, and SNRIs are options for pharmacological interventions. Hydrotherapy, mindfulness, CBT (cognitive-behavioral therapy), and physical exercise are the main non-pharmacological tools for long-term disease management. Continuous monitoring of the patient and precise modifications to interventions are essential for the success of therapy. The continuous education of patients, with detailed information, is essential for them to be empowered to manage their own symptoms, and consequently, improve their condition. This research examines the best clinical practices and prospective medical advancements for the treatment of fibromyalgia, as well as various therapeutic methods.